Israeli-German lab launched to study neurological illnesses

Rehovot-based institute to conduct research into cognitive, emotional and behavioral diseases.

March 6, 2014 04:15
1 minute read.
Weizmann Institute

Signing ceremony in Rehovot, from left, Max Planck Society president Peter Gruss and Weizmann’s Prof. Alon Chen and president Prof. Daniel Zajfman.. (photo credit: WEIZMANN INSTITUTE OF SCIENCE)


Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later Don't show it again

The Weizmann Institute in Rehovot and the Max Planck Society in Germany signed a cooperation agreement for joint research in cognitive, emotional, behavioral and neurological disorders.

Some 450 million people around the world suffer from some form of mental illness alone.

Be the first to know - Join our Facebook page.

The Max Planck-Weizmann Laboratory for Experimental Neuropsychiatry and Behavioral Neurogenetics will be located in Rehovot and headed by Prof. Alon Chen of Weizmann.

The agreement was signed at Weizmann on Tuesday by Max Planck Society president Prof. Dr.

Peter Gruss; Weizmann Institute president Prof. Daniel Zajfman; Max Planck general secretary Dr. Ludwig Kronthaler; and Weizmann vice president Prof. Haim Garty.

Lab researchers will conduct basic studies on the causes of these disorders, about which it is becoming increasingly clear that they arise from a complex interplay between genetics and environment, Chen said. The field of neuropsychiatry attempts to untangle this relationship and understand the process by which genetic makeup and variations in physical brain structure lead to particular behaviors or mental illness.

Researchers from the German and Israeli institutes will directly address such complex psychiatric disorders as depression, schizophrenia, anxiety and autism, using a wide range of multidisciplinary research methods, from the genomic and biochemical to the clinical. According to the agreement, the laboratory will support joint research projects of scientists at the two institutes, host joint seminars and symposia, arrange exchanges of visiting scientists and students, and create opportunities for research students to get joint training.

Related Content

August 31, 2014
Weizmann scientists bring nature back to artificially selected lab mice